Australia, May 19 -- Lava Therapeutics N.V., owns the trademark (2489441) for 'LAVA THERAPEUTICS' till Sept. 24, 2031.
Status: protected:
Registered/protected
Classes: 1 [Antibodies for scientific and research use; libraries of antibodies and collections of antibodies for scientific and research use; proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use in the manufacture of medicines.], 5 [Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders.] and 44 [Providing medical information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders via a website.]
Type of Mark: Word
Date of Acceptance: March 10
Registration Advertised: May 18
For further details contact Abion UK Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2489441.
Disclaimer: Curated by HT Syndication.
